Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Return on Invested Capital (2016 - 2025)

Lisata Therapeutics filings provide 11 years of Return on Invested Capital readings, the most recent being 1.07% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital fell 38.0% year-over-year to 1.07%, compared with a TTM value of 1.07% through Dec 2025, down 38.0%, and an annual FY2025 reading of 0.77%, down 22.0% over the prior year.
  • Return on Invested Capital hit 1.07% in Q4 2025 for Lisata Therapeutics, down from 1.0% in the prior quarter.
  • The five-year high for Return on Invested Capital was 0.37% in Q2 2023, with the low at 1.07% in Q4 2025.
  • Median Return on Invested Capital over the past 3 years was 0.63% (2024), compared with a mean of 0.66%.
  • The sharpest move saw Return on Invested Capital dropped -21bps in 2024, then crashed -38bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.46% in 2023, then plummeted by -49bps to 0.68% in 2024, then crashed by -56bps to 1.07% in 2025.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 1.07%, 1.0%, and 0.87% for Q4 2025, Q3 2025, and Q2 2025 respectively.